Charles Lane
Charles is senior reporter focusing on special projects. He has won numerous awards including an IRE award, three SPJ Public Service Awards, a National Murrow, and he was a finalist for the Livingston Award for Young Journalists.
In 2020 he reported the podcast Everytown which uncovered the plot to evict a group of immigrants from the Hamptons. He also started WSHU’s C19 podcast. Previous projects include investigations into FEMA and continuing coverage of financial regulation.
-
The measure, which now heads to the House, would roll back federal policies aimed at protecting minority buyers from discriminatory loan terms. The vote could lead to the rollback of other rules. -
Spotify's much-anticipated debut on the New York Stock Exchange arrived today — but the company has never made a profit. To do so, it needs to predict, and define, the future. -
The Senate-passed bill sharply reduces the number of banks that have to go through annual "stress tests" to determine whether they could survive an economic downturn or financial crisis.
-
The Department of Justice and 45 states allege that generic- drug makers colluded to divvy up customers and set prices. Prosecutors are now looking at potential involvement by drug distributors. -
Men between the ages of 18 and 34 have been a key demographic for marketers for years. That's starting to change, say some marketing experts, who say the economic fortunes of these men have declined.
-
Spotify's IPO, slated for this spring, gives investment banks a smaller role in the company's trading. It's been seen as a sign of Spotify's strength, but there are many unanswered questions. -
Being able to deduct local income and property taxes, evens things out — but the House Republican plan in the works eliminates most of those reductions, meaning no tax savings. -
To work all the expected flood claims, insurance companies will rely on hundreds of small processing companies. Some worry that inexperienced claims adjusters will do more harm than good. -
The man who caused a firestorm of criticism after he bought a small pharmaceutical company and jacked up the price of a life-saving drug was found guilty Friday of securities fraud. Martin Shkreli was convicted on three of the eight fraud charges he faced and could be sentenced to a prison term of as much as 20 years.
-
Opponents of Venezuelan President Nicolas Maduro are accusing Goldman Sachs of propping up the Maduro government with its recent purchase of Venezuelan bonds. Goldman bought the bonds at a steep discount and stands to make a lot of money if the country stabilizes. But it's not clear the money Venezuela received will ease food and medicine shortages.
